学会・論文発表[実績]

学会・論文発表

目次

著書 - Japanese Books

  1. 笠原正登、栢分節夫、鳥本一匡
    夜間頻尿と睡眠障害の関連についての最新の知見
    睡眠障害診療29のエッセンス(別冊・医学のあゆみ):61-65,2017
  2. 瀬田公一、福谷明直、笠原正登
    利尿薬の薬理作用と利尿薬抵抗性のメカニズム
    薬局 Vol.68 No.7: 66-71,2017.
  3. 森潔、土田潤一、桒原孝成、横井秀基、笠原正登、向山政志、柳田素子
    TLR4と関連因子
    Heart View 12(増刊号):168-171,2015.
  4. 森潔、桒原孝成、横井秀基、笠原正登、向山政志、柳田素子
    急性腎障害のバイオマーカー動向
    臨床化学 43:5-8,2014.
  5. 笠原正登
    疾患・病態別栄養ケア・マネジメント 腎・尿路疾患
    食物と栄養学基礎シリーズ10: 学文社
    臨床栄養学: 151-155, 2013.
  6. 笠原正登
    透析室での臨床研究 ― 研究デザインと研究のまとめ方
    臨床透析 29(4): 419-425, 2013.
  7. 笠原正登
    造影剤腎症
    心CT 9: 117-121, 2011.
  8. 笠原正登、曽根淳史、菅谷公男、大岡均至、平山暁秀
    夜間頻尿ガイドライン「病因と発症機序」
    日本排尿機能学会夜間頻尿診療ガイドライン作成委員会編: 13-18, 2009.

Publications

  1. Akira Ishii, Goro Katsuura, Hirotaka Imamaki, Hiroyuki Kimura, Keita P. Mori, Takashige Kuwabara, Masato Kasahara, Hideki Yokoi, Kousaku Ohinata, Tomoko Kawanishi, Junichi Tsuchida, Yuji Nakamoto, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama , Kiyoshi Mori
    Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice
    Scientific Reports 7, Article number: 15501 ,2017
  2. Ono S, Kume S*, Yasuda-Yamahara M, Yamahara K, Takeda N, Chin-Kanasaki M, Arai H, Sekine O, Yokoi H, Mukoyama M, Uzu T, Araki SI, Maegawa H.
    O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
    Nephrol Dial Transplant. in press.
  3. Sato Y, Fujimoto S, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T.
    Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population.
    PLoS One. May 16;12(5),2017.
  4. Iseki K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Konta T, Kasahara M, Shibagaki Y, Yoshida H, Moriyama T, Kondo M, Iseki C, Watanabe T;
    “Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by Specific Health Check”..
    Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.
    Clin Exp Nephrol. Mar 3,2017.
  5. Kato Y, Mori K, Kasahara M, Osaki K, Ishii A, Mori KP, Toda N, Ohno S, Kuwabara T, Tokudome T, Kishimoto I, Saleem MA, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H.
    Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition.
    Sci Rep. Apr 21;7,2017.
  6. Toda N, Mori K, Kasahara M, Ishii A, Koga K, Ohno S, Mori KP, Kato Y, Osaki K, Kuwabara T, Kojima K, Taura D, Sone M, Matsusaka T, Nakao K, Mukoyama M, Yanagita M, Yokoi H
    Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis.
    Sci Rep. Feb 13;7,2017.
  7. Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K.
    Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy.
    J Am Soc Nephrol. Jan;28(1):278-289,2017.
  8. Ohno S, Yokoi H, Mori K, Kasahara M, Kuwahara K, Fujikura J, Naito M, Kuwabara T, Imamaki H, Ishii A, Saleem MA, Numata T, Mori Y, Nakao K, Yanagita M, Mukoyama M.
    Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure.
    Sci Rep.Jun 7;6,2017.
  9. Fan Y, Futawaka K, Koyama R, Fukuda Y, Hayashi M, Imamoto M, Miyawaki T, Kasahara M, Tagami T, Moriyama K.
    Vitamin D3/VDR resists diet-induced obesity by modulating UCP3 expression in muscles.
    J Biomed Sci.Jul 29;23(1):56,2016.
  10. Futawaka K, Tagami T, Fukuda Y, Koyama R, Nushida A, Nezu S, Yamamoto H, Imamoto M, Kasahara M, Moriyama K.
    Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3 analogs.
    J Mol Endocrinol. Jul;57(1):23-32,2016.
  11. Futawaka K, Tagami T, Fukuda Y, Koyama R, Nushida A, Nezu S, Imamoto M, Kasahara M, Moriyama K.
    Growth hormone regulates the expression of UCP2 in myocytes.
    Growth Horm IGF Res.Aug;29:57-62,2016.
  12. Moriyama K, Yamamoto H, Futawaka K, Atake A, Kasahara M, Tagami T.
    Molecular characterization of human thyroid hormone receptor β isoform 4.
    Endocr Res. 41(1):34-42,2016.
  13. Kamei K, Konta T, Hirayama A, Ichikawa K, Kubota I, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Narita I, Kondo M, Shibagaki Y, Kasahara M, Asahi K, Watanabe T.
    Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.
    Clin Exp Nephrol. Jun;21(3):497-503,2017.
  14. Kimura G, Kasahara M, Ueshima K, Tanaka S, Yasuno S, Fujimoto A, Sato T, Imamoto M, Kosugi S, Nakao K.
    Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
    Clin Exp Nephrol. Jun;21(3):417-424,2017.
  15. Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K.
    Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic
    Nephropathy. J Am Soc Nephrol. Jan;28(1):278-289,2017.
  16. Koshiba T, Nishiuchi T, Akaihata H, Haga N, Kojima Y, Kubo H, Kasahara M, Hayashi M.
    Evaluating the Imbalance Between Increasing Hemodialysis Patients and Medical Staff Shortage After the Great East Japan Earthquake: Report From a Hemodialysis Center Near the Fukushima Nuclear Power Plants.
    Ther Apher Dial. Apr;20(2):127-34,2016.
  17. Li JE, Futawaka K, Yamamoto H, Kasahara M, Tagami T, Liu TH, Moriyama K.
    Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.
    Am J Chin Med. 43(5):879-92,2015.
  18. Moriyama , Yamamoto , Futawaka , Atake , Kasahara, Tagami,
    Molecular characterization of human thyroid hormone receptor β isoform 4.
    Endocr Res. 41(1):34-42,2015.
  19. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M, Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
    Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
    PLoS One. Jul 10;10 (7),2015.
  20. Uchida D, Kawarazaki H, Shibagaki Y, Yasuda T, Tominaga N, Watanabe T, Asahi K, Iseki K, Iseki C, Tsuruya K, Yamagata K, Moriyama T, Narita I, Fujimoto S, Konta T, Kondo M, Kasahara M, Kimura K.
    Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population.
    Clin Exp Nephrol. Jun;19(3):474-80,2015.
  21. Koga K, Yokoi H, Mori K, Kasahara M, Kuwabara T, Imamaki H, Ishii A, Mori KP, Kato Y, Ohno S, Toda N, Saleem MA, Sugawara A, Nakao K, Yanagita M, Mukoyama M.
    MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Diabetologia. Sep;58 (9):2169-80,2015.
  22. J. Kanda, K. Mori, H. Kawabata, T. Kuwabara, K.P. Mori, H. Imamaki, M. Kasahara, H. Yokoi, C. Mizumoto, N.K. Thoennissen, H.P. Koeffler, J. Barasch, A. Takaori-Kondo, M. Mukoyama, K. Nakao.
    An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.
    Clin. Exp. Nephrol. Feb;19(1):99-106, 2015.
  23. Moriyama , Yamamoto , Futawaka , Atake , Kasahara, Tagami
    Molecular characterization of human thyroid hormone receptor β isoform 4.
    Endocr Res. 41(1):34-42, 2016.
  24. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M, Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
    Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
    PLoS One. Jul 10;10 (7), 2015.
  25. Li JE, Futawaka K, Yamamoto H, Kasahara M, Tagami T, Liu TH, Moriyama K.
    Cinnamaldehyde Contributes to Insulin Sensitivity by Activating PPARδ, PPARγ, and RXR.
    Am J Chin Med. 43(5):879-92, 2015.
  26. Koga K, Yokoi H, Mori K, Kasahara M, Kuwabara T, Imamaki H, Ishii A, Mori KP, Kato Y, Ohno S, Toda N, Saleem MA, Sugawara A, Nakao K, Yanagita M, Mukoyama M. Micro
    RNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Diabetologia. Sep;58 (9):2169-80, 2015.
  27. J. Kanda, K. Mori, H. Kawabata, T. Kuwabara, K.P. Mori, H. Imamaki, M. Kasahara, H. Yokoi, C. Mizumoto, N.K. Thoennissen, H.P. Koeffler, J. Barasch, A. Takaori-Kondo, M. Mukoyama, K. Nakao.
    An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.
    Clin. Exp. Nephrol. 19(1):99-106, 2015.
  28. M. Kasahara, T. Nakagawa, H. Yokoi, T. Kuwabara, S. Yasuno, K. Mori, M. Mukoyama, K. Ueshima.
    Do statins play a role in renoprotection?
    Clin. Exp. Nephrol. Apr;18(2):282-5, 2014.
  29. J. Kanda, K. Mori, H. Kawabata, T. Kuwabara, K.P. Mori, H. Imamaki, M. Kasahara, H. Yokoi, C. Mizumoto, N.K. Thoennissen, H.P. Koeffler, J. Barasch, A. Takaori-Kondo, M. Mukoyama, K. Nakao.
    An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions.
    Clin. Exp. Nephrol. in press. Feb;19(1):99-106,2015.
  30. T. Kuwabara, K. Mori, M. Kasahara, H. Yokoi, H. Imamaki, A. Ishii, K. Koga, A. Sugawara, S. Yasuno, K. Ueshima, T. Morikawa, Y. Konishi, M. Imanishi, A. Nishiyama, K. Nakao, M. Mukoyama.
    Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.
    PLoS One. 9(2): e88942, 2014.
  31. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, K. Nakao.
    Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
    Clin. Exp. Nephrol. Aug;18(4):584-92, 2014
  32. K. Ueshima, M. Kasahara, D. Koya, T. Babazono, T. Sato, M. Imamoto, S. Yasuno, A. Fujimoto, S. Tanaka, G. Kimura, K. Nakao.
    Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
    Clin. Exp. Nephrol. 17(2): 211-217, 2013.
  33. H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, N. Toda, R. Yamada, S. Namoto, T. Yamamoto, N. Seki, N. Souma, T. Yamaguchi, A. Sugawara, M. Mukoyama, K. Nakao.
    Peritoneal Fibrosis and High Transport Are Induced in Mildly Pre-injured Peritoneum by 3,4-Dideoxyglucosone-3-ene in Mice.
    Perit. Dial. Int. 33(2): 143-154, 2013.
  34. H. Yokoi, M. Kasahara, K. Mori, Y. Ogawa, T. Kuwabara, H. Imamaki, Kawanishi T, K. Koga, A. Ishii, Y. Kato, K.P. Mori, N. Toda, S. Ohno, H. Muramatsu, T. Muramatsu, A. Sugawara, M. Mukoyama, K. Nakao.
    Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Kidney Int. 81(2): 160-169, 2012.
  35. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, Y. Kato, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, T. Tokudome, I. Kishimoto, A. Sugawara, K. Nakao.
    Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury.
    J. Am. Soc. Nephrol. 23(7): 1198-1209, 2012.
  36. Y.M. Nakao, S. Teramukai, S. Tanaka, S. Yasuno, A. Fujimoto, M. Kasahara, K. Ueshima, K. Nakao, S. Hinotsu, K. Nakao, K. Kawakami.
    Effects of renin-angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis.
    Diabetes Res. Clin. Pract. 96(1): 68-75, 2012.
  37. Y.M. Nakao, T. Miyawaki, S. Yasuno, K. Nakao, S. Tanaka, M. Ida, M. Hirata, M. Kasahara, K. Hosoda, K. Ueshima, K. Nakao.
    Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: Metabolic syndrome and abdominal obesity (MERLOT study).
    Proc. Japan Acad. Ser. B: Phys. Biol. Sci. 88(8): 454-461, 2012.
  38. K. Minakata, K. Bando, S. Takanashi, H. Konishi, Y. Miyamoto, K. Ueshima, T. Sato, Y. Ueda, Y. Okita, I. Masuda, H. Okabayashi, H. Yaku, S. Yasuno, H. Muranaka, M. Kasahara, S. Miyata, Y. Okamura, M. Nasu, K. Tanemoto, K. Arinaga, Y. Hisashi, R. Sakata.
    Impact of diabetes mellitus on outcomes in Japanese patients undergoing coronary artery bypass grafting.
    Journal of cardiology 59(3): 275-284, 2012.
  39. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, Y. Ogawa, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
    Exacerbation of diabetic nephropathy by Hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Diabetologia 55(8): 2256-2266, 2012.
  40. Mori K., Mukoyama M., Kasahara M., Yokoi H., Nakao K.
    Disease biomarkers for CKD.
    Japanese journal of clinical medicine. 70(5), 2012, 864-868.
  41. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, K. Kuwahara, J. Fujikura, Y. Arai, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mine.
    Nephrol. Dial. Transplant. 25(7): 2120-2124, 2010.
  42. M.Tanaka, T.Suganami, S.Sugita, Y.Shimoda, M. Kasahara, S. Aoe, M. Takeya, S. Takeda , Y. Kamei, Y. Ogawa.
    Role of Central Leptin Signaling in Renal Macrophage Infiltration.
    Endocr. J. 57(1): 61-72, 2010.
  43. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, T. Yoshioka, Y. Ogawa, H. Imamaki, T. Kusakabe, K. Ebihara, M. Omata, N. Satoh, A. Sugawara, J. Barasch, K. Nakao.
    Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.
    Kidney Int. 75(3): 285-294, 2009.
  44. M. Kasahara, K. Mori, N. Satoh, T. Kuwabara, H. Yokoi, A. Shimatsu, A. Sugawara, M. Mukoyama, K. Nakao.
    Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients.
    Nephrol. Dial. Transplant. 24(8): 2608-2609, 2009.
  45. H. Yokoi, M. Mukoyama, K. Mori, M. Kasahara, T. Suganami, K. Sawai, T. Yoshioka , Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Overexpression of connective tissue growth factor worsens diabetic nephropathy in mice.
    Kidney Int. 73(4): 446-455, 2008.
  46. T.Nagae, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Suganami, K. Sawai, T. Yoshioka, M. Koshikawa, Y. Saito, Y. Ogawa, T. Kuwabara, I. Tanaka, A. Sugawara, T. Kuwahara, K. Nakao.
    Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis.
    Kidney Int 74(1): 70-80, 2008.
  47. K. Sawai, M. Mukoyama, K. Mori, M. Kasahara, M. Koshikawa, H. Yokoi, T. Yoshioka , Y. Ogawa, A. Sugawara, H. Nishiyama, S. Yamada, T. Kuwahara, M.A. Saleem, K. Shiota, O. Ogawa, M. Miyazato, K. Kangawa, K. Nakao.
    Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.
    Am. J. Physiol. Renal Physiol. 293(4): F1363-1372, 2007.
  48. T. Babazono, H. Nakamoto, K. Kasai, S. Kuriyama, T. Sugimoto, M. Nakayama, C. Hamada, R. Furuya, H. Hasegawa, M. Kasahara, M. Moriishi, T. Tomo, M. Miyazaki, M. Sato, N. Yorioka, Y. Kawaguchi.
    Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
    Am. J. Nephrol. 27 (4): 409-415, 2007.
  49. H. Makino, M. Mukoyama, K. Mori, T. Suganami, M. Kasahara, K. Yahata, T. Nagae, H. Yokoi, K. Sawai, Y. Ogawa, S. Suga, Y. Yoshimasa, A. Sugawara, I. Tanaka, K. Nakao.
    Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice.
    Diabetologia 49(10): 2514-2524, 2006.
  50. H.Nakamoto, T. Babazono, K. Kasai, S. Kuriyama, T. Sugimoto, M. Nakayama, C. Hamada, R. Furuya, H. Hasegawa, M. Kasahara, M. Moriishi, T. Tomo, M. Miyazaki, N. Yorioka, M. Sato, K. yamabe, Y. Kawaguchi.
    Successful use of icodextrin in elderly patients on continuous ambulatory peritoneal dialysis.
    Advances in Peritoneal Dialysis. 21: 168-174, 2005.
  51. M. Goto, M. Mukoyama, A. Sugawara, T. Suganami, M. Kasahara, K. Yahata, H. Makino, S. Suga, I. Tanaka, K. Nakao.
    Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats.
    Hypertens. Res. 25(1): 125-133, 2002.
  52. T. Suganami, I. Tanaka, M. Mukoyama, M.Kotani, S.Muro, K. Mori, M. Goto, R. Ishibashi, M. Kasahara, K. Yahata, H. Makino, A. Sugawara, K. Nakao.
    Altered growth response to prostaglandin E2 and its receptor signaling in mesangial cells from stroke-prone spontaneously hypertensive rats.
    J. Hypertens. 19(6): 1095-1103, 2001.
  53. T. Suganami, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, M. Kasahara, K. Yahata, H. Makino, Y Fujinaga, Y. Ogawa, I. Tanaka, K. Nakao.
    Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury.
    J. Am. Soc. Nephrol. 12(12): 2652-2663, 2001.
  54. K. Fujikawa, M. Kasahara, Y. Matsui, H Takeuchi.
    Human atrial natriuretic peptide is a useful criterion in treatment of nocturia.
    Scand. J. Urol. Nephrol. 35(4):310-313, 2001.
  55. T. Nagae, M. Mukoyama, A. Sugawara, K. Mori, K. Yahata, M. Kasahara, T. Suganami, H. Makino, Y. Fujinaga, T. Yoshioka, I. Tanaka, K. Nakao.
    Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy.
    Biochem. Biophys. Res. Commun. 270(1): 89-93, 2000.
  56. N. Tamura, Y. Ogawa, H. Chusho, K. Nakamura, K. Nakao, M. Suda, M. Kasahara, R. Hashimoto, G. Katsuura, M. Mukoyama, H. Itoh, Y. Saito, I. Tanaka, H. Otani, M. Katsuki, K. Nakao.
    Cardiac fibrosis in mice lacking brain natriuretic peptide.
    Proc. Natl. Acad. Sci. USA. 97(8): 4239-4244, 2000.
  57. M. Kasahara, M. Mukoyama, A. Sugawara, H. Makino, T. Suganami, Y. Ogawa, M. Nakagawa, K. Yahata, M. Goto, R. Ishibashi, N. Tamura, I. Tanaka, K. Nakao.
    Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation.
    J. Am. Soc. Nephrol. 11(9): 1691-1701, 2000.
  58. M. Goto, M. Mukoyama, S. Suga, T. Matsumoto, M. Nakagawa, R. Ishibashi, M. Kasahara, A. Sugawara, I. Tanaka, K. Nakao.
    Growth-Dependent Induction of Angiotensin II Type 2 Receptor in Rat Mesangial Cells.
    Hypertension. 30(3): 358-362, 1997.

Presentations

  1. G. Kimura, M. Kasahara, S. Tanaka, A. Fujimoto, T. Sato, M. Imamoto, S. Kosugi, K. Ueshima, K. Nakao.
    Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Principal results of Assessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
    Kidney Week (2013)
  2. S. Yasuno, K. Ueshima, S. Tanaka, A. Fujimoto, M. Kasahara, Y.M. Nakao, T. Ogihara, T. Saruta, K. Nakao.
    Type 2 diabetes and a history of coronary heart disease are additive cardiovascular risks in high-risk hypertensive patients.
    European Society of Cardiology (2013)
  3. S. Yasuno, K. Ueshima, K. Oba, M. Kasahara, A. Fujimoto, Y.M. Nakao, T. Miyawaki, I. Masuda, K. Nakao.
    Impact of blood pressure on new-onset of proteinuria in Japanese population. MIYAKO (Multicenter Investigation for Yearly medical check Assessment in KyotO) surveillance.
    EuroPRevent (2013)
  4. Y. Kato, M. Mukoyama, H. Yokoi, K. Mori, M. Kasahara, Y. Ogawa, T. Kuwabara, I. Kishimoto, A. Sugawara, K. Nakao.
    p38 MAPK signaling mediates aldosterone-induced renal injury in natriuretic peptide receptor (GC-A)-deficient mice.
    ISARSH (2013)
  5. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, H. Imamaki, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
    Macrophage-mediated glucolipotoxicity via MRP8/TLR4 signaling in diabetic nephropathy.
    World Congress of Nephrology (2013)
  6. K. Koga, M. Mukoyama, H. Yokoi, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, A. Ishii, K.P. Mori, Y. Kato, S. Ohno, N. Toda, M.A. Saleem, A. Sugawara, K. Nakao.
    microRNA-26a attenuates TGF-[beta]-induced extracellular matrix production by inhibiting CTGF and Smad2 in diabetic nephropathy.
    World Congress of Nephrology (2013)
  7. K.P. Mori, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, H. Imamaki, A. Ishii, K. Koga, Y. Kato, N. Toda, S. Ohno, T. Endo, M. Yanagita, A. Sugawara, K. Nakao.
    Megalin-Independent reabsorption of low molecular weight proteins at collecting ducts revealed by drug-inducible megalin knockout mice.
    World Congress of Nephrology (2013)
  8. K.P. Mori, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, H. Imamaki, A. Ishii, A. Sugawara, K. Nakao.
    High fat diet- or fasting-induced renal lipid deposition is differentially associated with changes in systemic and renal lipid-modulating factors.
    World Congress of Nephrology (2013)
  9. T.Kuwabara, K.Mori, M.Mukoyama, M.Kasahara, H.Yokoi, H.Imamaki, A.Ishi, K.Koga, K.P.Mori, Y.Kato, A.Sugawara, K.Nakao
    Macrophage-mediated glucolipotoxicity via MRP8/TLR4 signaling in diabetic nephropathy
    World Congress of Nephrology, satellite Synposium (2013)
  10. K.P.Mori, K.Mori, M.Mukoyama, H.Yokoi, M.Kasahara, T.Kuwabara, H.Imamaki, A.Ishii, A.Sugawara, K.Nakao
    High fat diet- or fasting-induced renal lipid deposition is differentially associated with changes in systemic and renal lipid-modulating factors
    World Congress of Nephrology, satellite Synposium (2013)
  11. N. Toda, H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, H. Imamaki, K. Koga, A. Ishii, Y. Kato, K.P. Mori, S. Ohno, A. Sugawara, T. Matsusaka, K. Nakao, M. Mukoyama.
    Systemic Deletion of CTGF Ameliorates Anti-Glomerular Basement Membrane Nephritis with Reduction of Macrophage Infiltration.
    American Society of Nephrology (2013)
  12. M. Kasahara, K. Ueshima, D. Koya, T. Babazono, M. Imamoto, S. Yasuno, A. Fujimoto, S. Tanaka, G. Kimura, K. Nakao.
    Effects of Atorvastatin on Renal Function in Patients with Dyslipidemia and Chronic Kidney Disease: Design of the ASsessment of Clinical Usefulness in CKD Patients with Atorvastatin (ASUCA) Trial.
    American Society of Nephrology, Kidney Week(2012)
  13. Y. Kato, M. Mukoyama, H. Yokoi, Y. Ogawa, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Nakao.
    Role of p38 mapk in aldosterone-induced glomerular injury in natriuretic peptide receptor-a deficient mice.
    Hypertension (2012)
  14. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, H. Imamaki, A. Ishii, K. Koga, K.P. Mori, Y. Kato, N. Toda, S. Ohno, A. Sugawara, K. Nakao.
    Macrophage-mediated glucolipotoxicity contributes to progression of diabetic nephropathy through MRP8/TLR4 signaling.
    American Society of Nephrology (2012)
  15. A. Ishii, H. Imamaki, K. Mori, M. Mukoyama, H. Yokoi, M. Kasahara, T. Kuwabara, Y. Ogawa, T. Kawanishi, K. Koga, K.P. Mori, Y. Kato, N. Toda, S. Ohno, A. Sugawara, K. Nakao.
    Role of kidney injury biomarker Ngal in obesity and energy homeostasis
    American Society of Nephrology (2012)
  16. K. Koga, M. Mukoyama, H. Yokoi, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K.P. Mori, Y. Kato, S. Ohno, N. Toda, M.A. Saleem, A. Sugawara, K. Nakao.
    microRNA-26a is upregulated in glomeruli of diabetic mice and attenuates TGFβ1-induced extracellular matrix expression in podocytes by inhibiting both CTGF and SMAD2.
    American Society of Nephrology (2012)
  17. K. Koga, M. Mukoyama, H. Yokoi, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K.P. Mori, Y. Kato, S. Ohno, N. Toda, A. Sugawara, K. Nakao.
    Analyses of microRNAs targeting CTGF in peritoneal fibrosis mouse model.
    American Society of Nephrology (2012)
  18. K.P. Mori, M. Mukoyama, H. Yokoi, M. Kasahara, T. Kuwabara, H. Imamaki, Y. Ogawa, T. Kawanishi, A. Ishii, K. Koga, Y. Kato, N. Toda, S. Ohno, A. Sugawara, K. Nakao.
    Alteration of renal lipid deposition and gene expression induced by fasting and high-fat diet feeding.
    American Society of Nephrology (2012)
  19. K.P. Mori, K. Mori, M. Mukoyama, H. Yokoi, M. Kasahara, T. Kuwabara, H. Imamaki, A. Ishii, K. Koga, Y. Kato, A. Sugawara, T. Endo, M. Yanagita, K. Nakao.
    Acute disruption of megalin expression in renal cortex reveals compensatory reabsorption capacity of low molecular weight proteins in S3 segment of proximal tubules and collecting ducts.
    American Society of Nephrology (2012)
  20. Y. Kato, M. Mukoyama, H. Yokoi, Y. Ogawa, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, I. Kishimoto, A. Sugawara, K. Nakao.
    p38 MAP kinase mediates aldosterone-induced podocyte injury in natriuretic peptide receptor (GC-A)-deficient mice.
    American Society of Nephrology (2012)
  21. N. Toda, H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, H. Imamaki, K. Koga, A. Ishii, Y. Kato, K.P. Mori, S. Ohno, A. Sugawara, M. Mukoyama, K. Nakao.
    Inducible CTGF (CCN2) Knockout Mice Attenuates Anti-Glomerular Basement Membrane Nephritis.
    American Society of Nephrology (2012)
  22. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, Y. Ogawa, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, M. Imanishi, A. Nishiyama, A. Sugawara, K. Nakao.
    Hyperlipidemia promotes diabetic renal injury via TLR4 signaling.
    World Congress of nephrology (2011)
  23. K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
    Incomplete tubular compensation model for albuminuria in diabetes.
    World Congress of nephrology (2011)
  24. K. Mori, J. Kanda, M. Mukoyama, H. Kabata, M. Kasahara, H. Yokoi, T. Kuwabara, K. Nakao.
    The kidney and neutrophils are the major sources of acute kidney injury biomarker Ngal.
    World Congress of nephrology (2011)
  25. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, Y. Kato, K.P. Mori, H. Muramatsu, T. Muramatsu, A. Sugawara, K. Nakao.
    Pleiotrophin causes peritoneal inflammation and mesothelial cell proliferation in a mouse model of peritoneal fibrosis.
    World Congress of nephrology (2011)
  26. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
    Toll-Like Recepotor 4-Mediated, Hyperinsulinemia-Independent Progression of Diabetic Nephropathy by Hyperlipidemia.
    American Diabetes Association (2011)
  27. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, Y. Kato, A. Sugawara, K. Nakao.
    Aggravation of diabetic nephropathy by hyperlipidemia is mediated by MRP8/TLR4 signaling in macrophages.
    American Society of Nephrology (2011)
  28. T. Kawanishi, M. Kasahara, H. Yokoi, T. Kuwabara, H. Imamaki, A. Ishii, K. Koga, Y. Kato, K.P. Mori, K. Ueshima, S. Tanaka, S. Yanaka, A. Sugawara, K. Nakao.
    Urinary level of Ngal is superior to urinary protein in prediction of chronic kidney disease progression.
    American Society of Nephrology (2011)
  29. K. Koga, H. Yokoi, M. Mukoyama, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K.P. Mori, Y. Kato, M.A. Saleem, A. Sugawara, K. Nakao.
    Functional analysis of miR-30c, miR-26a and miR-379 in podocytes and their potential roles in diabetic nephropathy.
    American Society of Nephrology (2011)
  30. Y. Kato, M. Mukoyama, H. Yokoi, Y. Ogawa, K. Mori, M. Kasahara, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K.P. Mori, A. Sugawara, K. Nakao.
    Blockade of p38 MAPK pathway ameliorates aldosterone-induced renal injury in guanylyl cyclase-A deficient mice.
    American Society of Nephrology (2011)
  31. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Ogawa, H. Imamaki, T. Kawanishi, A. Sugawara, K. Nakao.
    Synergistic aggravation of albuminuria, tubular lipid accumulation and macrophage infiltration by combination of hyperglycemia and hyperlipidemia, inparallel with inflammation and extracellular matrix expression.
    14th International Congress of Endocrinology (2010)
  32. H. Imamaki, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, M. Satou, K. Nakatani, Y. Saito, Y. Ogawa, T. Kawanishi, N. Tomosugi, A. Sugawara, K. Nakao.
    Nutritional status but not iron determines serum neutrophil gelatinase-assoc iated lipocalin (Ngal) levels in maintenance hemodialysis patients
    14th International Congress of Endocrinology (2010)
  33. S. S. Muro. Oki, K.Usui, A. Shimatsu, Y. Osaki, T. Inomoto, K. Mori, H. Yokoi, M. Kasahara, M. Mukoyama, K. Nakao.
    A case of insulinoma effectively controlled with octreotide acetate
    14th International Congress of Endocrinology (2010)
  34. M. Mukoyama, M. Kasahara, K. Mori, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, A. Sugawara, K. Nakao.
    Overexpression of Connective Tissue Growth Factor in Podocytes Worsens Diabe tic Nephropathy by Reducing MMP-2 Activity.
    14th International Congress of Endocrinology (2010)
  35. T. Kawanishi, S. S. Muro. Oki, U. Ken, A. Shimatsu, Y. Osaki, T. Inomono, K. Mori, H. Yokoi, M. Kasahara, M. Mukoyama, K. Nakao.
    A case of insulinoma effectively controlled with octreotide acetate
    14th International Congress of Endocrinology (2010)
  36. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, H. Muramatsu, T. Muramatsu, A. Sugawara, K. Nakao.
    Microarray analysis of peritoneum in experimental peritoneal fibrosis identifies pleiotrphin, an inflammatory factor.
    International Symposium on Cardiovascular Endocrinology and Metabolism (2010)
  37. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, I. Kishimoto, A. Sugawara, K. Nakao.
    Renoprotective role of natriuretic peptide receptor guanylyl cyclase-A signaling in mineralocorticoid receptor-mediated glomerular injury.
    International Symposium on Cardiovascular Endocrinology and Metabolism (2010)
  38. K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Ogawa, T. Kuwabara, H. Makino, T. Suganami, A. Sugawara, K. Nakao.
    Optimal Dose of Natriuretic Peptide for Renal Protection.
    International Symposium on Cardiovascular Endocrinology and Metabolism (2010)
  39. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, K. Kuwahara, J. Fujikura, Y. Arai, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, A. Sugawara, K. Nakao.
    Podocyte-Specific Expression of Tamoxifen-inducible Cre Recombinase in Mice.
    ISN Nexus Symposium (2010)
  40. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, I. Kishimoto, A. Sugawara, K. Nakao.
    Natriuretic peptide receptor guanylyl cyclase-A signaling exerts antagonisti c effects on the local rennin-angiotensin-aldosterone system in kidney.
    ISN Nexus Symposium (2010)
  41. K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, Y. Ogawa, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, A. Sugawara, K. Nakao.
    Incomplete tubular compensation model for albuminuria in diabetic nephropathy.
    ISN Nexus Symposium 2010 "The Kidney and the Vascular System" (2010)
  42. T. Kuwabara, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Yoshioka, H. Imamaki, T. Kawanishi, A. Ishii, K. Koga, K. Nakao.
    Diabetes and high fat diet synergistically aggravate glomerular and tubular.
    ISN Nexus Symposium 2010 "The Kidney and the Vascular System" (2010)
  43. H. Imamaki, M. Mukoyama, M. Kasahara, H. Yokoi, T. Kuwabara, Y. Ogawa, T. Kawanishi, T. Kuwahara, M. Sato, J. Barrasch, A. Sugawara, K. Nakao.
    Reverse epidemiology of circulating Ngal (or lipocalin 2) levels in end-stage renal disease.
    ISN Nexus Symposium 2010 "The Kidney and the Vascular System" (2010)
  44. M. Kasahara, H. Yokoi, K. Mori, N. Iga, T. Ishimura, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, K. Koga, A. Ishii, A. Sugawara, M. Mukoyama, K. Nakao.
    The N- and L-type calcium channel blocker cilnidipine reduces albumin uria in diabetic db/db mice.
    ISH2010
  45. H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, T. Kawanishi, K. Koga, A. Ishii, K. Mori, Y. Kato, A. Sugawara, M. Mukoyama, K. Nakao.
    Atrial natriuretic peptide prevents peritoneal adhesion formation with inhibiting macrophage and CD3-positive cell infiltration.
    American Society of Nephrology (2010)
  46. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, T. Kuwabara, A. Sugawara, K. Nakao.
    Podocyte-Specific Expression of Tamoxifen-inducible Cre Recombinase in Mice.
    American Society of Nephrology (2010)
  47. H. Yokoi, M. Kasahara, K. Mori, T. Kuwabara, R. Yamada, S. Namoto, T. Yamamoto, N. Seki, T. Yamaguchi, N. Souma, A. Sugawara, M. Mukoyama, K. Nakao.
    The role of 3,4-dideoxyglucosone-3-ene in peritoneal fibrosis.
    American Society of Nephrology (2010)
  48. K. Koga, M. Mukoyama, H. Yokoi, K. Mori, M. Kasahara, T. Kuwabara, Y. Ogawa, H. Imamaki, T. Kawanishi, A. Ishii, K. Mori, Y. Kato, M.A. Saleem, A. Sugawara, K. Nakao.
    MicroRNA expression analysis in angiotensinⅡ-stimulated human podocytes and its glomerular expression in diabetic mice.
    American Society of Nephrology (2010)
  49. M. Mukoyama, Y. Ogawa, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, I. Kishimoto, A. Sugawara, K. Nakao.
    Protective effects of natriuretic peptide receptor guanylyl cyclase-A signaling on aldosterone-induced glomerular injury.
    World Congress of nephrology (2009)
  50. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, H. Muramatsu, T. Muramatsu, A. Sugawara, K. Nakao.
    Microarray analysis of peritoneum in experimental peritoneal fibrosis identifies pleiotrphin, a profibrotic and inflamma tory factor.
    World Congress of nephrology (2009)
  51. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, N. Iga, T. Ishimura, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, A. Sugawara, K. Nakao.
    Renoprotective effects of the N- and L-type calcium channel blocker cilnidipine in diabetic db/db mice.
    World Congress of nephrology (2009)
  52. K. Mori, T. Kuwabara, M. Kasahara, N. Satoh, Y. Saito, H. Yokoi, H. Imamaki, T. Nagae, Y. Ogawa, T. Kawanishi, J. Barasch, A. Sugawara, M. Mukoyama, K. Nakao.
    Urinary excretion of ker ngal is increased in diabetic nephropathy by impaired tubular reabsorption, which can be attenuated by angiotensin receptor blockade.
    World Congress of nephrology (2009)
  53. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, T. Kawanishi, H. Muramatsu, T. Muramatsu, A. Sugawara, K. Nakao.
    Role of a Novel Growth Factor, Pleiotrophin, in Peritoneal Fibrosis
    American Society of Nephrology (2009)
  54. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, T. Kawanishi, I. Kishimoto, A. Sugawara, K. Nakao.
    Renoprotective role of natriuretic peptide receptor guanylyl cyclase-A signaling in aldosterone-induced glomerular injury.
    American Society of Nephrology (2009)
  55. H. Imamaki, K. Mori, T. Kuwabara, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Saito, Y. Ogawa, T. Kawanishi, A. Ishii, K. Koga, A. Sugawara, K. Nakao.
    Serum Neutrophil Gelatinase-Assosiated Lipocalin Levels are determined by Nurtritional Status and White Blood Cell Counts but Not by Iron in Maintenance Hemodialysis Patients.
    American Society of Nephrology (2009)
  56. H. Yokoi, M. Mukoyama, M. Kasahara, K. Mori, K. Sawai, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    The Shiga International Symposium on Diabetic Nephropathy (2009)
  57. K. Mori, T. Kuwabara, M. Mukoyama, Y. Saito, M. Kasahara, H. Yokoi, Y. Ogawa, H. Imamaki, K. Nakao.
    Urinary Ngal as an early biomarker for diabetic nephropathy in mice.
    The Shiga International Symposium on Diabetic Nephropathy (2009)
  58. T. Nagae, K. Mori, M. Mukoyama, M. Kasahara, H. Yokoi, T. Suganami, K. Sawai, T. Yoshioka, M. Koshikawa, Y. Saito, Y. Ogawa, T. Kuwabara, I. Tanaka, A. Sugawara, T. Kuwahara, K. Nakao.
    Adrenomedullin gene transfer into rat kidney ameliorates obstructive renal fibrosis through inhibition of connective tissue growth factor and extracellular signal-regulated kinase.
    International Society of Hypertension (2008)
  59. K. Mori, T. Kuwabara, M. Mukoyama, M. Kasahara, H. Yokoi, Y. Ogawa, Y. Saito, H. Imamaki, A. Sugawara, J. Barasch, K. Nakao.
    Urinary Ngal is a kidney injury biomarker which integrates information of damage in glomeruli, proximal tubules and distal nephrons.
    International Society of Hypertension (2008)
  60. M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, K. Sawai, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Overproduction of Connective Tissue Growth Factor (CTGF) in Podocytes Worsens Diabetic Nephropathy in Mice: Paracrine role of Podocyte CTGF.
    ENDO (2008)
  61. T. Nagae, M. Mukoyama, K. Mori, M. Kasahara, H. Yokoi, K. Sawai, T. Yoshioka, M. Koshikawa, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao,
    Adrenomedullin Gene Transfer in Rat Kidney Inhibits Connective Tissue Growth Factor, Extracellular Signal-Regulated Kinase, and Renal Fibrosis.
    ENDO (2008)
  62. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Microarray Analysis of Peritoneum in Experimental Peritoneal Sclerosis Identifies Pleiotrophin, a Potential Cell Proliferating and Chemotactic Factor.
    The 12th Congress of the International Society for Peritoneal Dialysis (2008)
  63. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Expression of Pleiotrophin, Cell Proliferating Factor in peritoneal Fibrosis Medel Mice and Human Peritoneum.
    American Society of Nephrology (2008)
  64. Y. Ogawa, M. Mukoyama, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Protective effect of atrial natriuretic peptide receptor guanylyl cyclase-A signaling on aldosterone-induced renal injury.
    American Society of Nephrology (2008)
  65. T. Kuwabara, K. Mori, Y. Saito, M. Mukoyama, M. Kasahara, H. Yokoi, T. Yoshioka, Y. Ogawa, A. Sugawara, K. Nakao.
    Neutrophil gelatinase-associated lipocalin (NGAL) is a uniquely increased low molecular weight protein in early stage diabetic nephropathy.
    10th International Symposium of Nephrology (2007)
  66. M. Kasahara, M. Mukoyama, K. Mori, H. Yokoi, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwahara, A.Sugawara, K. Nakao.
    Renoprotective Effect of Atrial Natriuretic Peptide in Acute Renal Failure.
    World Congress of Nephrology (2007)
  67. T. Kuwabara, K. Mori, M. Mukoyama, Y. Saito, M. Kasahara, H. Yokoi, T. Yoshioka, Y. Ogawa, A. Sugawara, K. Nakao.
    Neutrophil gelatinase-associated lipocalin (Ngal) as a new biomarker for diabetic nephropathy.
    World Congress of Nephrology (2007)
  68. H. Yokoi, M. Mukoyama, M. Kasahara, K. Mori, K. Sawai, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Overexpression of connective tissue growth factor (CTGF) in poducytes deteriorates diabetic nephropathy in mice.
    Congress of the European Renal Association European Dialysis and Transplant Association (2007)
  69. T. Kuwabara, K. Mori, M. Mukoyama, Y. Saito, M. Kasahara, H. Yokoi, T. Yoshioka, Y. Ogawa, H. Imamaki, A. Sugawara, J. Barasch, K. Nakao.
    Distinct urinary excretion of albumin, beta-2 microglobulin (β2MG) and neutrophil gelatinase-associated lipocalin (Ngal) in mouse models of diabetic nephropathy (DN).
    American Society of Nephrology (2007)
  70. K. Mori, T. Kuwabara, M. Mukoyama, M. Kasahara, H. Yokoi, T. Yoshioka, Y. Ogawa, Y. Saito, H. Imamaki, A. Sugawara, J. Barasch, K. Nakao.
    Blood and urinary neutrophil gelatinase-associated lipocalin (Ngal) levels in the treatment courses of proteinuric glomerular diseases.
    American Society of Nephrology (2007)
  71. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Microarray analysis of peritoneum experimental peritoneal sclerosis identifies pleiotrophin, a potential cell proliferating factor.
    American Society of Nephrology (2007)
  72. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Podocyte-specific and tamoxifen-inducible Cre-mediated recombination in mice.
    American Society of Nephrology (2007)
  73. K. Sawai, M. Mukoyama, K. Mori, H. Yokoi, M. Koshikawa, T. Yoshioka, M. Kasahara, Y. Saito, Y. Ogawa, A. Sugawara, R. Takeda, O. Ogawa, T. Kuwahara, M.A. Saleem, K. Nakao.
    Redistribution of connexin 43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    39th Annual Meeting of the American Society of Nephrology (2006)
  74. H. Yokoi, M. Mukoyama, M. Kasahara, K. Mori, K. Sawai, M. Koshikawa, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Role of CTGF (CCN2) in the progression of diabetic nephropathy in mice with disarranged podocin expression.
    39th Annual Meeting of the American Society of Nephrology (2006)
  75. M. Kasahara, M. Mukoyama, K. Mori, H. Yokoi, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Renoprotective Effect of Atrial Natriuretic Peptide in Acute Renal Failure in Humans.
    31th Annual Meeting of the International Society of Blood Purifiction (2006)
  76. H. Yokoi, M. Mukoyama, M. Kasahara, K. Mori, T. Suganami, K. Sawai, M. Koshikawa, A. Sugawara, K. Nakao.
    Overexpression of connective tissue growth factor (CTGF) in podocytes deteriorates nephropathy in diabetic mice.
    38th Annual Meeting of the American Society of Nephrology (2005)
  77. H. Yokoi, M. Mukoyama, M. Nagata, M. Kasahara, K. Sawai, T. Nagae, M. Koshikawa, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, A. Sugawara, K. Nakao.
    Selective inhibition of TGF-β type I recepter(ALK5)reduces renal fibrosis in unilateral urerteral obstruction.
    38th Annual Meeting of the American Society of Nephrology (2005)
  78. M. Kasahara, A. Yoshimoto, M. Mukoyama, A. Sugawara, K. Nakao, T. Suzuki.
    Renoprotective effect of atrial natiruretic peptide in acute renal failure in humans.
    37th Annual Meeting of the American Society of Nephrology (2004)
  79. M. Kasahara, A. Yoshimoto, T. Suzuki.
    Evasion from dialysis induction, using atrial natriureric peptide.
    ERA-EDTA (2004)
  80. M. Kasahara, A. Yoshimoto, M. Mukoyama, A. Sugawara, K. Nakao, T. Suzuki.
    Renoprotective Effect of Atrial Natriuretic Peptide in Acute Renal Failure in Humans.
    ASN (2004)
  81. M. Mukoyama, A. Yoshimoto, T. Suganami, H. Yokoi, T. Nagae, K. Sawai, T. Yoshioka, M. Koshikawa, M. Kasahara, A. Sugawara, K. Nakao.
    Upregulation of connective tissue growth factor during experimental encapsulating peritoneal sclerosis in mice.
    36th Annual Meeting of the American Society of Nephrology (2003)
  82. M. Kasahara, T. Tokoro, M. Yoshikawa, T. nitta, M. Okuno, Y. Mastushima, I. Sakaji, T. Suzuki.
    A new trial of a peritoneal dialysis induction method (SMAP).
    23th Annual Dialysis Conference (2003)
  83. Y. Ishida, M. Kasahara, I. Sakaji, M. Yoshikawa, T. Nitta, Y. Matsushima, Y. Iwatani, A. Yoshimoto, T. Suzuki.
    Consideration of Coagulant Free Hemodialysis from Our experience.
    23th Annual Dialysis Conference (2003)
  84. Y. Matsushima, A. Yoshimoto, I. Sakaji, M. Yoshikawa, T. Nitta, M. Okuno, Y. Ishida, M. Mukoyama, M. Kasahara, T. Suzuki.
    Significance of measurement for colloid osmotic pressure during hemodialysis.
    ASN (2003)
  85. M. Kasahara, T. Tokoro, M. Yoshikawa, T. Nitta, M. Okuno, Y. Mastushima, I. Sakaji, T. Suzuki.
    Atrial Natriuretic Pepide (ANP) is The Hormone which lets Acute Renal Failure Patient evade from Dialysis Induction.
    ASN (2003)
  86. A. Yoshimoto, M. Mukoyama, T. Suganami, K. Mori, A. Sugawara, M. Kasahara, H. Makino, T. Nagae, Y. Fujinaga, K. Sawai, H. Yokoi, T. Yoshioka, M. Koshikawa, K. Nakao.
    Protective Effects of Brain Natriuretic Peptide on Peritubular Capillary and Interstitial Fibrosisi in obstructive Nephropathy.
    35th Annual Meeting of the American Society of Nephrology (2002)
  87. T. Ishii, I. Sakaji, M. Miyata, S. Fukube, A. Matsuda, M. Kasahara, T. Suzuki.
    Additional Hemodiafiltration with Plasma exchange for Acute Hepatic Failure increase survival rate.
    ASN (2002)
  88. I. Sakaji, M. Kasahara, T. Tokoro, M. Yoshikawa, T. Nitta, M. Miyata, M. Kubota, M. Horimoto, T. Suzuki, H. Hasegawa.
    Additional hemodiafiltration with plasma exchange survive patients from fulminant hepatic failure.
    ERA-EDTA (2002)
  89. T. Suganami, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae, M. Kasahara, K. Yahata, H. Makino, Y. Y. Fujinaga. Ogawa, I. Tanaka, K. Nakao.
    Overexpression of Brain Natriuretic Peptide in Mice Ameliorates Immune-Mediated Renal Injury by Inhibiting MCP-1 and TGF-β Expression.
    33nd Annual Meeting of the American Society of Nephrology (2000)
  90. A. Yoshimoto, K. Mori, K. Hosoda, A. Sugawara, M. Mukoyama M. Kasahara, K. Yahata, T. Suganami, H. Makino, H. Hosoda, M. Kojima, K. Kangawa, K. Nakao.
    Renal Expression of Ghrelin: A Novel Molecule Which Stimulates Growth Hormone Secretion.
    33nd Annual Meeting of the American Society of Nephrology (2000)
  91. T. Nagae, M. Mukoyama, A. Sugawara, K. Mori, K. Yahata, M. Kasahara, T. Suganami, H. Makino, Y. Fujinaga, T. Yoshida, I. Tanaka, K. Nakao.
    Cloning and Expression of Rat Receptor-Activity-Modifying Proteins for Adrenomedullin/CGRP Receptor and Their Marked Upregulation in Obstructive Nephropathy.
    33nd Annual Meeting of the American Society of Nephrology (2000)
  92. M. Mukoyama, A. Sugawara, M. Kasahara, T. Suganami, K. Mori, K. Yahata, H. Makino, Y. Ogawa, I. Tanaka, K. Nakao.
    Ameliorated renal injury in mice overproducing brain natriuretic peptide with nephropathy.
    11 th International congress of Endocrinology (2000)
  93. M. Mukoyama, M. Goto, A. Sugawara, T. Suganami, M. Kasahara, R. Ishibashi, K. Yahata, H. Makino, I. Tanaka, K. Nakao.
    Angiotenshin Ⅱrecepter subtypes and mesangial cell gorwth regulation: role of AT2 receptor In MAP kinase cascade Inhibition and apoptosis Induction.
    15th International Congress of Nephrology. (1999)
  94. M. Kasahara, M. Mukoyama, T. Suganami, H. Makino, T. Nagae , K. Yahata, R. Ishibashi, Y. Ogawa, A. Sugawara, I. Tanaka, K. Nakao.
    Chronic excess of brain natriuretic peptide in transgenic mice inhibits glomerular hypertropathy and renal fibrosis following renal Injury.
    15th International Congress of Nephrology (1999)
  95. H. Makino, M. Mukoyama, T. Suganami, K. Yahata, M. Kasahara, R. Ishibashi, T. Nagae , Y. Fujinaga, A. Sugawara, I. Tanaka, K. Nakao.
    Cloning and expression of rat connective tissue growth factor and its marked induction in Streptozotocin induced diabetic rat kidney.
    15th International Congress of Nephrology (1999)
  96. M. Kasahara, M. Mukoyama, H. Makino, T. Suganami, K. Yahata, Y. Ogawa, A. Sugawara, I. Tanaka, K. Nakao.
    Inhibited glomerular hypertrophy follwing renal ablation In transgenics for brain natriuretic peptide.
    1th Meeting of Asian-Pacific Society of Hypertension. (1999)
  97. M. Kasahara, M. Mukoyama, A. Sugawara, T. Nagae, T. Suganami, H. Makino, K. Yahata, Y. Fujinaga, Y. Ogawa, I. Tanaka, K. Nakao.
    Chronic Overproduction of Brain Natriuretic Peptide in Transgenic Mice Ameliorates Tubulointerstitial Damage Following Unilateral Ureteral Obstruction.
    32nd Annual Meeting of the American Society of Nephrology (1999)
  98. T. Suganami, M. Mukoyama, A. Sugawara, T. Nagae, M. Kasahara, K. Yahata, H. Makino, Y. Fujinaga, Y. Ogawa, I. Tanaka, K. Nakao.
    Chronic Excess of Brain Natriuretic Peptide in Transgenic Mice Ameliorates Proteiuria and Mesangial Proliferation in Anti-GBN Nephritis.
    32nd Annual Meeting of the American Society of Nephrology (1999)
  99. T. Nagae, M. Mukoyama, A. Sugawara, K. Yahata, H. Makino, M. Kasahara, T. Suganami, Y.Fujinaga, K. Mori, I. Tanaka, K. Nakao.
    Cloning of a Family of Rat Receptor-Activity-Modifying Proteins (RAMP) for Adrenomedullin Receptor, and Their Expression in Rat Kidney.
    32nd Annual Meeting of the American Society of Nephrology (1999)
  100. H. Makino, M. Mukoyama, T. Suganami, K. Yahata, M. Kasahara, R. Ishibashi, Y.Fujinaga, T. Nagae, A. Sugawara, I. Tanaka, K. Nakao.
    Cloning of Rat Connective Tissue Growth Factor and Ⅰst Expression in Streptozotocin-Induced Diabetic Rat Kidoney.
    32nd Annual Meeting of the American Society of Nephrology (1999)
  101. M. Mukoyama, M. Goto, M. Kasahara, M. Kotani, R. Ishibashi, K. Yahata, T. Suganami, H. Makino, A. Sugawara, I. Tanaka, K. Nakao.
    Expression and role of angiotensin II AT2 receptor in the kidney of normotensive and spontaneously hypertensive rats
    2nd International Forum "The Frontiers of Nephrology" (1998)
  102. M. Goto, M. Mukoyama, I. Tanaka, R. Ishibashi, M. Kasahara, K. Yahata, T. Suganami, H. Makino, A. Sugawara, K. Nakao.
    Type 2 angiotensin II (AT2) receptor inhibits MAP kinase cascade and induces apoptosis in rat mesangial cells.
    17th Scientific Meeting of the International Society of Hypertension (1998)
  103. M. Kasahara, M. Mukoyama, I. Tanaka, H. Makino, T. Suganami, M. Goto, R. Ishibashi, K. Yahata, Y. Ogawa, A. Sugawara, K. Nakao.
    Chronic overproduction of brain natriuretic peptide limits glomerular hypertrophy in mice with reduced renal mass.
    17th Scientific Meeting of the International Society of Hypertension (1998)
  104. M. Goto, M. Mukoyama, T. Suganami, M. Kotani, R. Ishibashi, M. Kasahara, K. Yahata, H. Makino, A. Sugawara, I. Tanaka, K. Nakao.
    Role of MAP kinase cascade inhibition by AT2 angiotensin II receptor in antiproliferative and proapoptotic action in cultured mesangial cells.
    31st Annual Meeting of the American Society of Nephrology (1998)
  105. M. Kasahara, M. Mukoyama, I. Tanaka, T. Suganami, H. Makino, M. Goto, R. Ishibashi, K. Yahata, Y. Ogawa, A. Sugawara, K. Nakao.
    Inhibited mesangial expansion and glomerular hypertrophy following renal ablation in mice transgenic for brain natriuretic peptide.
    31st Annual Meeting of the American Society of Nephrology (1998)
  106. M. Kasahara, S. Muro, I. Tanaka, A. Sugawara, M. Mukoyama, M. Kotani, R. Ishibashi, K. Nakao.
    Augmented gene expression of prostaglandinn E receptor EP1 subtype in tha nepron in hypertensive rat (SHR-SP).
    30th Annual Meeting of the American Society of Nephrology (1997)
  107. M. Goto, M. Mukoyama, R. Ishibashi, M. Kasahara, K. Yahata, S. Suga, A. Sugawara, I. Tanaka, K. Nakao.
    Angiotensin II AT2 receptor mediates ant-proliferative and apoptotic action in cultured rat mesangial cells.
    30th Annual Meeting of the American Society of Nephrology (1997)
  108. M. Goto, M. Mukoyama, S. Suga, T. Matsumoto, M. Nakagawa, R. Ishibashi, M. Kasahara, A. Sugawara, I. Tanaka, K. Nakao.
    Expression of AT2 Recepter in Rat Kidney and its Anti-Proliferative Role in Cultured Rat Mesangial Cells.
    The American Society of Nephrology 29th Annual Meeting (1996)

国際シンポジウム - International Symposiums

  1. M. Kasahara, K. Ueshima, D. Koya, T. Babazono, T. Sato, M. Imamoto, S. Yasuno, A. Fujimoto, S. Tanaka, G. Kimura, K. Nakao.
    Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the Assessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
    World Congress of Nephrology, satellite Synposium (2013)
  2. K. Mori, J. Kanda, M. Mukoyama, H.Kawabata, M. Kasahara, H. Yokoi, T. Kuwabara, C.Mizumoto, K. Nakao.
    The kidney and neutrophil as the sources of an acute kidney injury biomarker Ngal.
    ISN Nexus Symposium 2010 "The Kidney and the Vascular System" (2010)
  3. M. Mukoyama, Y. Ogawa, H. Yokoi, M. Kasahara, K. Mori, T. Yoshioka, Y. Saito, T. Kuwabara, H. Imamaki, I. Kishimoto, A. Sugawara, K. Nakao.
    Renoprotective role of natriuretic peptide receptor guanylyl cyclase-A signaling in aldosterone-induced podocyte injury.
    ENDO (2009)
  4. K. Mori, T. Kuwabara, M. Mukoyama, Y. Saito, M. Kasahara, H. Yokoi, Y. Ogawa, H. Imamaki, K. Nakao.
    Urinary Ngal as an early biomarker for diabetic nephropathy in mice.
    The Shiga International Symposium on Diabetic Nephropathy (2008)
  5. H. Yokoi, M. Kasahara, M. Mukoyama, K. Mori, T. Yoshioka, Y. Saito, Y. Ogawa, T. Kuwabara, H. Imamaki, A. Sugawara, K. Nakao.
    Microarray analysis of peritoneum experimental peritoneal sclerosis identifies pleiotrophin, a potential cell proliferating and chemotactic factor.
    The 3rd Asian chapter meeting of international society of peritoneal dialysis (2007)
    11th International Symposium of Nephrology (2007)

邦文学術論文 - Japanese Papers

  1. 中川媛世、伊藤雪絵、笠原正登、澤見一枝
    地域在住高齢者の主観的健康観に関する要因の検討
    日本看護学会ヘルスプロモーション
  2. 笠原正登
    心血管疾患と慢性腎臓病の論理的解釈-Evidenceからの考察-
    室医会報 学術特集号17巻: 21-25, 2016.
  3. 笠原正登、木村玄次郎、上嶋健治、田中佐智子、保野慎治、藤本明、佐藤俊哉、今本美幸、小杉眞司、中尾一和
    脂質異常合併CKD患者に対するアトルバスタチンの腎保護効果の検討(ASUCAトライアル)
    日本腎臓学会誌56(3): 287, 2014.
  4. 森慶太、笠原正登
    hANP(カルペリチド)
    循環器内科第75(3): 280-287 2014.
  5. 森 潔、桒原孝成、横井秀基、笠原正登、向山政志、柳田素子
    急性腎障害のバイオマーカー動向
    臨床化学43(1): 5-8, 2014.
  6. 森 潔、桒原孝成、横井秀基、笠原正登、向山政志、中尾一和
    薬剤性AKIの早期診断と予防法
    臨床透析 29(11): 1565-1572, 2013.
  7. 瀬田公一、笠原正登
    造影剤腎症の病態と対策.
    Circulation 3(7): 97-104, 2013.
  8. 武田正之、横山修、内村直尚、笠原正登
    夜間頻尿~注意しなくてはならない多尿と睡眠障害~
    泌尿器外科 26(7): 1091-1098, 2013.
  9. 森 潔、桒原孝成、横井秀基、笠原正登、向山政志, 中尾一和
    Neutrophil gelatinase-associated lipocalinによる病態解析
    臨床検査 57(6): 617-622, 2013.
  10. 森慶太、笠原正登
    慢性腎臓病をどう治療する
    冠動脈疾患のパーフェクトマネジメント 180-188, 2013.
  11. 石井輝、桒原孝成、笠原正登
    スタチン
    月刊糖尿病 5(11): 80-87, 2013.
  12. 森 潔、向山政志、笠原正登、横井秀基、中尾一和
    心腎貧血症候群の診断:バイオマーカーで診る
    Heart View 16(9): 898-904, 2012.
  13. 石井輝、小出達真、笠原正登
    利尿薬と電解質異常
    Circulation 2(9): 24-32, 2012.
  14. 桒原孝成、向山政志、森 潔、笠原正登、横井秀基、中尾一和
    ナトリウム利尿ペプチド
    カレントテラピー 30(8): 839-845, 2012.
  15. 森慶太、堀井和子、笠原正登
    臓器保護を見据えた降圧戦略 降圧療法におけるCa拮抗薬の役割(腎保護) ―糸球体上皮細胞に着目して―
    循環plus 12(10): 7-9, 2012.
  16. 桒原孝成、森 潔、向山政志、笠原正登、横井秀基、齋藤陽子、今牧博貴、川西智子、石井輝、古賀健一、森慶太、加藤有希子、菅原照、中尾一和
    高脂血症がもたらす糖尿病性腎症悪化の分子機構
    Therapeutic Research 33(2): 173-175, 2012.
  17. 藤堂祥子、上嶋健治、小林純子、長谷部美代子、福富まさ美、大江陽子、井上房子、中本まり子、田中佐智子、保野慎治、笠原正登、藤本明、中尾一和
    臨床試験における臨床検査中央測定システムについて:ASUCA試験参加医師へのアンケート調査の結果から
    臨床評価 40(1): 179-185, 2012.
  18. 中本まり子、上嶋健治、福富まさ美、大江陽子、井上房子、小林純子、藤堂祥子、長谷部美代子、田中佐智子、保野慎治、笠原正登、藤本明、中尾一和
    症例登録に関わる試験参加医師の背景因子についての検討:SAKURA試験参加医師のアンケート調査から
    臨床評価 40(1): 187-192, 2012.
  19. 森 潔、向山政志、笠原正登、横井秀基、中尾一和
    慢性腎臓病(CKD)
    日本臨床 70(5): 864-868, 2012.
  20. 桒原孝成、向山政志、森 潔、笠原正登、中尾一和
    ナトリウム利尿ペプチド系
    CKDのサイエンスー基礎と臨床―, 2011
  21. 桒原孝成、向山政志、森 潔、笠原正登、中尾一和
    心腎連関におけるナトリウム利尿ペプチドとNgal
    腎と透析 71(5): 685-691, 2011.
  22. 桒原孝成、向山政志、森 潔、笠原正登、中尾一和
    糖尿病性腎症における脂質代謝異常とその役割.
    カレントテラピー 29(8): 717-721, 2011.
  23. 笠原正登、森慶太、向山政志、中尾一和
    腎臓とナトリウム利尿ペプチド: ANPの腎保護効果, 腎臓での作用
    Modern Physician 31(6): 746-749, 2011.
  24. 植田浩司、笠原正登
    夜間頻尿の病態―治療へのアプローチのために―
    排尿障害プラクティス 19(2): 148-154, 2011.
  25. 保野慎治、上嶋健治、大庭幸治、中尾葉子、笠原正登、藤本明、宮脇尚志、桝田出、中尾一和
    慢性腎臓病発症予測因子の検討:健康診断データベースから見た生活習慣病の関わり
    健康管理事業団研究助成論文集 XXVII, 2011, 19-27.
  26. 横井秀基、笠原正登、向山政志
    腹膜透析による腹膜障害のメカニズム 成長因子・サイトカイン研究の進歩と展望.
    医学のあゆみ 239(7): 784-789, 2011.
  27. 森 潔、向山政志、笠原正登、中尾一和
    新規バイオマーカーからみた尿細管間質性腎障害
    日本腎臓学会誌53(4): 596-599, 2011.
  28. 森 潔、桒原孝成、笠原正登、今牧博貴、川西智子、横井秀基、向山政志、中尾一和
    Ngal
    Modern physician 31(1): 87-89, 2011.
  29. 笠原正登、坂地一朗
    「造影剤腎症への対策」-動脈硬化の内科的治療に迫る 薬物治療とインターベンション-
    新・心臓病診療プラクティス16, 2011.
  30. 森 潔、桒原孝成、今牧博貴、川西智子、笠原正登、横井秀基、向山政志、中尾一和
    新規バイオマーカー尿中Ngalによる慢性腎臓病の重症度、治療効果及び予後の評価
    腎臓 33(2): 109-112, 2010.
  31. 森 潔、桒原孝成、向山政志、笠原正登、佐藤哲子、横井秀基、小川喜久、今牧博貴、川西智子、古賀健一、石井輝、菅原照、中尾一和
    腎臓における尿中バイオマーカーNgalおよびアルブミンの代謝 Pharma Medica 28(5): 242-245, 2010.
  32. 桒原孝成、向山政志、笠原正登、森潔、中尾一和
    ナトリウム利尿ペプチド系
    CKDのサイエンス-基礎と臨床-: 99-108, 2010.
  33. 植田浩司、笠原正登
    夜間頻尿の病態
    排尿障害プラクティス18(1):25-31, 2010.
  34. 笠原正登、向山政志
    カルペリチド
    Medhical Practice 27(5): 832-834, 2010.
  35. 横井秀基、笠原正登、向山政志、森 潔、吉岡徹朗、齋藤陽子、小川喜久、桒原孝成、今牧博貴、菅原照、中尾一和
    マウス腹膜線維症モデルマウスにおける腹膜遺伝子発現変化の網羅的解析による新規増殖因子pleiotrophinの同定と機能解析
    腎と透析66(別冊 腹膜透析2009): 263-266, 2009.
  36. 笠原正登、植田浩司、戸田尚宏、横井秀基、森 潔、向山政志
    腎不全の発症機序とその対策
    臨床麻酔 33(5): 807-815, 2009.
  37. 笠原正登、向山政志、中尾一和
    急性心不全治療薬hANPの多彩な作用
    循環器科 66(1):80-88, 2009.
  38. 笠原正登、植田浩司、向山政志
    急性腎傷害(AKI)の保存的診療─造影剤腎症
    Intensivist 1(3): 543-550, 2009.
  39. 森 潔、向山政志、桒原孝成、笠原正登、横井秀基、中尾一和
    CKDにおける新規バイオマーカーNgalの意義
    日本臨床67(6): 1233-1241, 2009.
  40. 笠原正登、向山政志、森 潔、中尾一和
    αhANPの有用性 Heart View 12(3): 324-329, 2008.
  41. 向山政志、森 潔、笠原正登、中尾一和
    糖尿病性腎症の発症・進展抑制のための診療指針
    日本臨床66(増刊9): 256-260, 2008.
  42. 笠原正登、
    AKI での hANP 介入治療:積極的な立場から
    内科 102巻 999-1002, 2008.
  43. 笠原正登、松井勝、井上和久、越川真男、吉本明弘、坂地一朗、横井秀基、向山政志
    抗サイトカイン療法;急性血液浄化を中心として
    臨床サイトカイン学: 125-134, 2007.
  44. 笠原正登、吉本明弘、内藤嘉之
    サイトカインと急性血液浄化
    LiSA12(1): 40-44, 2005.
  45. 吉本明弘、笠原正登、鈴木隆夫、石田祐介、坂地一朗、吉川真由美、松嶋安代、新田輝、岩谷嘉仁、遠藤宏和、片山俊郎
    低分子ヘパリン(レビパリンNa)の各種膜に対する吸着性、透過性の検討(生食系の循環実験) : 東京医学社
    腎と透析 58(2): 231-235, 2005.
  46. 笠原正登、尾上千佳、岩崎徹、鄒美千代、坂井瑠実
    透析患者の脂質代謝に及ぼす低分子ヘパリン(レビパリンNa)の影響 -未分画ヘパリン(UFH),他の低分子ヘパリンとの比較-
    透析室の環境整備 -- 院内感染を含めて: 日本メディカルセンター
    臨牀透析2004 20(8): 121-128, 2004.
  47. 吉本明弘、笠原正登、鈴木隆夫
    当院におけるSMAP法による腹膜透析導入に関して
    大阪CAPD研究会会誌17: 24-27, 2004.
  48. 松井豊、笠原正登
    エクストラニールを用いて血液透析併用の離脱が可能となったCAPD症例の検討
    大阪CAPD研究会会誌17: 34-40, 2004.
  49. 笠原正登、上浦望、吉本明弘
    PCI後の腎障害
    Coronary Intervention 11(3): 370-37, 2004.
  50. 笠原正登、吉本明弘、鈴木隆夫
    ナトリウム利尿ペプチドの考え方 -腎保護に注目した使用法-
    Therapeutic Research 25(2): 305-313, 2004.
  51. 笠原正登、吉本明弘、上浦望、鈴木隆夫
    病態と疾患からみたナトリウム利尿ペプチド 「急性腎不全」
    日本臨床(増刊号 臨床分子内分泌学(1-心血管内分泌代謝系(上)-))62(9): 103-106, 2004.
  52. 笠原正登、吉本明弘、鈴木隆夫
    腎循環
    救急医学 28(2): 153-157, 2004.
  53. 笠原正登、吉本明弘、鈴木隆夫、所敏子
    腹膜炎発症時にカテーテル再挿入は有効か?
    腎と透析57(別冊 腹膜透析2004): 319-321, 2004.
  54. 吉本明弘、笠原正登、上浦望、鈴木隆夫、橋本隆
    当院におけるSMAP-B法に関する検討
    腎と透析57(別冊 腹膜透析2004): 252-253, 2004.
  55. 山口容子、成島佳代、平石夕起、藤中咲千子、鶴亀美幸、河田妙子、吉本明弘、笠原正登、鈴木隆夫
    高齢者のCAPD患者を抱える家族への在宅に向けた援助
    腎と透析57(別冊 腹膜透析2004): 174-176, 2004.
  56. 南めぐみ、島脇里美、鶴亀美幸、河田妙子、吉本明弘、笠原正登、鈴木隆夫
    ライフスタイルに合わせた出口部の選択に向けた援助
    腎と透析57(別冊 腹膜透析2004): 155-157, 2004.
  57. 村田ゆかり、平岡雅美、日高瑞貴、鶴亀美幸、河田妙子、吉本明弘、笠原正登、鈴木隆夫
    腎不全保存期の患者指導の検討-よりよい腎不全保存期指導を目指して-
    腎と透析57(別冊 腹膜透析2004): 139-140, 2004.
  58. 笠原正登、武田和夫、浅野健一郎、梅津道夫、深川雅史、山内 淳
    腎疾患とアンジオテンシンⅡ受容体拮抗薬
    診療と新薬 39(9): 735-751, 2002.
  59. 菅波高祥、向山政志、菅原照、森 潔、永江徹也、槇野久士、笠原正登、八幡兼成、藤永有理子、小川桂宏、田中一成、中尾一和
    ナトリウム利尿ペプチドの抗糸球体基底膜抗体腎炎(抗GBM腎炎)における腎保護作用
    Pharma Medica 20(6): 126-128, 2002.
  60. 向山政志、笠原正登、菅波孝祥、森 潔、菅原照、中尾一和
    Na利尿ペプチドの腎保護作用とその機序:遺伝子操作マウスを用いた検討
    心臓33(1): 51-54, 2001.
  61. 向山政志、笠原正登、菅原照、森 潔、菅波孝祥、槇野久士、八幡兼成、永江徹也、藤永有理子、吉本明弘、澤井一智、横井秀基、吉岡徹朗、田中一成、中尾一和
    ナトリウム利尿ペプチドによる腎保護作用とその機序-高度腎摘腎障害および間質線維化モデルを用いた検討-
    血圧7(7): 648-652, 2000.
  62. 菅波高祥、向山政志、菅原照、森 潔、永江徹也、槇野久士、笠原正登、八幡兼成、藤永有理子、小川桂宏、田中一成、中尾一和
    抗糸球体基底膜抗体腎炎におけるナトリウム利尿ペプチドの腎保護作用-BNP-過剰発現マウスを用いた検討―
    Therapeutic Research 21(5): 1051-1054, 2000.
  63. 笠原正登、向山政志、菅波孝祥、槇野久士、小川佳宏、中川真代、後藤昌久、八幡兼成、石橋里江子、菅原照、田中一成、中尾一和
    Na利尿ペプチドの腎保護作用とその機序-BNPトランスジェニックマウスを用いた検討-
    Therapeutic Research 20(5): 1335-1339, 1999.
  64. 向山政志、後藤昌久、菅波孝祥、石橋里江子、笠原正登、八幡兼成、槇野久士、菅原照、田中一成、中尾一和
    アンジオテンシンⅡ受容体サブタイプとメサンギウム細胞増殖調節
    Terapeutic Research 20(3): 785-790, 1999.

邦文総説 - Reviews

  1. 森 潔、向山政志、笠原正登、横井秀基、中尾一和
    CKDのバイオマーカー
    日本臨床 70(5): 864-868, 2012.
  2. 笠原正登
    内科医が診る夜間頻尿 複雑な背景を解きほぐず.
    メディカル朝日40(6): 20-21, 2011.
  3. 笠原正登、向山政志、中尾一和
    CKDと脂質代謝異常
    Adiposcience 7: 352-358, 2011.
  4. 笠原正登
    透析医療費を考える
    臨牀透析27(3): 253-254, 2011.
  5. 笠原正登
    内科的疾患と多尿
    排尿障害プラクティス17(2): 92-97, 2009.
  6. 笠原正登、吉本明弘、橋本隆、鈴木隆夫
    腹腔鏡を用いたSMAP法
    腎と透析アクセス57: 33-42, 2004.
  7. 笠原正登、吉本明弘、鈴木隆夫
    SMAP法は腹膜透析を変えるか?
    大阪透析研究会会誌 22(1): 53-57, 2004.

邦文症例報告 - Case report

  1. 石井輝、笠原正登
    末梢神経障害と排尿困難を主訴に来院したネフローゼ症候群の1例/片腎摘出後に大量の胸腹水が出現した多発性嚢胞腎の1例―胸腹水貯留のメカニズムを考える
    内科 109(4): 715-718, 2012.
  2. 川西智子、向山政志、横井秀基、森 潔、小川喜久、桒原孝成、今牧博貴、古賀健一、石井 輝、白石裕介、兼松明弘、小川修、吉岡徹朗、菅原照、笠原正登、中尾一和
    腹膜透析を経て腎移植施行後に急性腎不全を発症した多発性嚢胞腎患者の一例
    腎と透析69 (別冊 腹膜透析2010):600-602, 2010.
  3. 福井伸行、向山政志、齋藤陽子、森 潔、笠原正登、横井秀基、小川喜久、 桒原孝成、中尾一和、菅原照
    家族性地中海熱による全身性AAアミロイドーシスを認めコルヒチンが奏功した1例
    日本内科学会誌97(12): 3046-3048, 2008.
  4. 笠原正登、山下力也、横井秀基、向山政志、吉岡徹朗、森 潔、齋藤陽子、小川喜久、桒原孝成、今牧博貴、深津敦司、菅原照、中尾一和
    気腫性胆嚢炎から腹膜炎を併発した腹膜透析患者の一症例
    腎と透析69(別冊 腹膜透析2008):418-420, 2008.
  5. 池田祥子、横井秀基、向山政志、笠原正登、森 潔、吉岡徹朗、齋藤陽子、小川喜久、桒原孝成、今牧博貴、深津敦司、菅原照、中尾一和
    腹膜透析中に左側大量胸水を認め、99mTc-Sn-colloid scintigraphyを用いて横隔膜交通症と診断した1例
    日本透析医学会雑誌 40(10):877-881, 2007.
  6. 吉岡徹朗、向山政志、内藤雅喜、中西道郎、原祐介、森 潔、笠原正登、横井秀基、澤井一智、越川真男、齋藤陽子、小川喜久、桒原孝成、川上利香、深津敦司、田中芳徳、原田昌樹、菅原照、中尾一和
    透析導入直後に尿毒症性心外膜炎による心タンポナーデを合併した糖尿病性腎症の1例
    日本透析医学会雑誌 40(7): 609-615, 2007.
  7. 所敏子、笠原正登、日野恵、鈴木隆夫、篠原尚吾、中島吉彦
    硬化性被嚢性腹膜炎(SEP)発症後に副甲状腺摘出術(PTX)を実施した2症例
    腎と骨代謝15(2): 218-219, 2002.
  8. 白倉永理、笠原正登、松原淳一、所敏子、鈴木隆夫
    多彩な臨床経過の後に腹膜透析を導入した蛋白漏出性胃腸症の一例
    大阪CAPD研究会会誌17: 21-25, 2002.
  9. 田中敬雄、笠原正登、宮脇尚志、八幡兼成、橋本英隆、上田恵、松尾孝彦、桑原隆
    選択的IgM欠損症に伴ったSLE腎症の一例
    日本腎臓学会誌38(4): 185-190, 1996.
  10. 田中敬雄、宮脇尚志、笠原正登、八幡兼成、橋本英隆、菅原 照、上田 恵、松尾孝彦、桑原 隆
    阪神・淡路大震災により発生した, I型マクロCreatine kinase (CK)血症を伴ったcrush syndromeの3例
    日本透析医学会雑誌29(3): 241-248, 1996.
  11. 笠原正登、吉政孝明、藤井茂彦、荒井宏司、中川 修、岸本一郎、小松弥郷、浜 典男、深田順一、島津 章、伊藤裕、田中一成、中尾一和
    Ganglioneuromaを合併し高血圧を呈したemptysellaを伴う下垂体前葉機能低下症の一症例
    ホルモンと臨床43(冬季増刊): 53-57, 1995.
  12. 宮脇尚志、菅原照、八幡兼成、笠原正登、橋本英隆、田中敬雄、上田恵、松尾孝彦、仙崎英人、桑原隆
    P-ANCA陽性のGoodpasture syndromeの一剖検例
    大阪府済生会中津病院年報5-2: 9-15, 1994.
  13. 横井秀基、菅波孝祥、田中一成、向山政志、菅真一、後藤昌久、中川真代、石橋里江子、笠原正登、伊藤裕、斎藤能彦、桝田出、菅原照、桑原隆、中尾一和
    悪性高血圧を呈した膜性腎症の一例
    Therapeutic Research 17(10): 3839-3834, 1996.

国内シンポジウム・学術集会

  1. 中川媛世、伊藤雪絵、笠原正登、澤見一枝
    地域在住高齢者の主観的健康観に関連する要因の検討
  2. M. Kasahara, M. Mukoyama, S. Yasuno, S. Tanaka, A. Fujimoto, K. Ueshima.
    Strategy of Renoprotection by Lipid Control
    第78回日本循環器学会シンポジウム Treatment Strategy of CKD: Collaboration by Cardiologists and Nephrologists 2014
  3. 笠原正登、上浦望、吉本明弘、鈴木隆夫
    エクストラニールの功罪について
    第4回日本在宅透析支援会議総会 2006
  4. 笠原正登、吉本明弘、橋本隆、鈴木隆夫
    腹腔鏡を用いたSMAP導入法の検討
    第7回アクセス研究会学術集会・総会 2003
  5. 笠原正登、橋本隆、所敏子、鈴木隆夫
    腹腔鏡を用いたSMAP導入方の検討
    第1回SMAPコロキウム 2002

ランチョンセミナー

  1. CKDにおける脂質制御の意義
    第36回日本高血圧学会総会2013
  2. 腎生理を考えた高血圧治療
    第42回日本腎臓学会西部学術大会2012
  3. RA系薬剤だけで腎疾患の治療は万全か ~スタチン系薬剤の腎保護作用に期待して~
    第35回日本高血圧学会総会2012
  4. 何故、腎蔵は障害をうけるのか -造影剤腎症と対策-
    第47回 日本医学放射線学会秋季臨床大会2011
  5. 脂質異常による腎障害の疫学的検討
    第41回日本腎臓学会西部学術大会2011
  6. 腎生理機能と心腎連関 -hANPの真の役割とは-
    第38回日本集中治療医学会2011
  7. 何故、腎臓は障害を受けるのか -腎生理機能と造影剤腎症-
    第97回日本循環器学会中国地方会2010
  8. 腎疾患治療の現状と展望 -腎生理機能を考慮した薬剤選択-
    第40回日本腎臓学会西部学術大会2010
  9. 心不全治療における 利尿薬の上手な使い方
    第58回日本心臓病フォーラム2010
  10. CKDにおける脂質制御の意義
    第39回日本IVR学会総会2010
  11. 腎生理機能とナトリウム利尿ペプチド -周術期におけるhANPの可能性-
    第37回日本集中治療医学会学術集会2010
  12. 造影剤が腎臓に及ぼす影響とその対策
    第45回日本放射線学会秋季臨床大会2009
  13. イメージで理解する造影剤腎症
    近畿脳神経血管内治療学会2008
  14. 腎臓におけるHanpの真の役割と心腎連関
    第25回Live Demonstration in KOKURA 2008
  15. 造影剤による腎障害 -腎臓専門医の立場から-
    第24回Live Demonstration in KOKURA 2007
  16. ナトリウム利尿ペプチドのpleiotropic effect-腎保護作用を考慮した治療戦略-
    日本麻酔科学中国四国学術集会2005
  17. ナトリウム利尿ペプチドのpleiotropic effect -腎保護に注目した使用法-
    日本集中治療学会2005
  18. 私のオピニオン-高齢者在宅腹膜透析を成功させるために-
    第49回日本透析医学会学術集会・総会2004
  19. Na利尿ペプチドの新しい考え方-腎保護に注目した使用法-
    第8回日本心臓血管麻酔学会学術大会2003